Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  76 results for ""BIMATOPROST""

Your Filters

Publisher : elsevier science
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study.

  • Authors : Fechtner R; Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University (R.F.), Syracuse, New York, USA. Electronic address: .; Mansberger S

Subjects: Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/drug therapy ; Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/physiopathology ; Latanoprost*/Latanoprost*/Latanoprost*/therapeutic use

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2024 Aug; Vol. 264, pp. 66-74. Date of Electronic Publication: 2024 Mar 16.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Development and validation of the stability indicating RP-UHPLC method for the determination of the chemical purity and assay of bimatoprost.

  • Authors : Zezula M; Pharmaceutical Research Institute, Warsaw 01-793, Poland. Electronic address: .; Ruszczak M

Subjects: Drug Contamination* ; Drug Stability*; Bimatoprost/Bimatoprost/Bimatoprost/*analysis

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2019 Sep 10; Vol. 174, pp. 348-359. Date of Electronic Publication: 2019 Jun 10.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.

Subjects: Absorbable Implants*; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2017 Mar; Vol. 175, pp. 137-147. Date of Electronic Publication: 2016 Dec 22.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Screening and quantification of undeclared PGF 2α analogs in eyelash-enhancing cosmetic serums using LC-MS/MS.

  • Authors : Rahman MS; Medi-Quality Security Institute (MQS), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan; Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyotanabe, Kyoto 610-0395, Japan. Electronic address: .

Subjects: Cosmetics* ; Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods; Antihypertensive Agents

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2022 Sep 20; Vol. 219, pp. 114940. Date of Electronic Publication: 2022 Jul 14.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Circadian Rhythm/Circadian Rhythm/Circadian Rhythm/*drug effects ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

  • Source: Survey of ophthalmology [Surv Ophthalmol] 2004 Mar; Vol. 49 Suppl 1, pp. S26-35.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Circadian Rhythm/Circadian Rhythm/Circadian Rhythm/*drug effects ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

  • Source: Survey of ophthalmology [Surv Ophthalmol] 2004 Mar; Vol. 49 Suppl 1, pp. S19-25.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Report

Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Cloprostenol/Cloprostenol/Cloprostenol/*analogs & derivatives ; Cloprostenol/Cloprostenol/Cloprostenol/*therapeutic use

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2004 Jan; Vol. 137 (1), pp. 210-1; author reply 211-2.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy ; Intraocular Pressure/Intraocular Pressure/Intraocular Pressure/*drug effects

  • Source: American journal of ophthalmology [Am J Ophthalmol] 2003 Jan; Vol. 135 (1), pp. 55-63.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Bimatoprost protects retinal neuronal damage via Akt pathway.

  • Authors : Takano N; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.; Tsuruma K

Subjects: Amides/Amides/Amides/*pharmacology ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology ; Cloprostenol/Cloprostenol/Cloprostenol/*analogs & derivatives

  • Source: European journal of pharmacology [Eur J Pharmacol] 2013 Feb 28; Vol. 702 (1-3), pp. 56-61. Date of Electronic Publication: 2013 Feb 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.

Subjects: Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*administration & dosage ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Glaucoma/Glaucoma/Glaucoma/*drug therapy

  • Source: Survey of ophthalmology [Surv Ophthalmol] 2001 May; Vol. 45 Suppl 4, pp. S361-8.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  76 results for ""BIMATOPROST""